Featured Research

Related Links

Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.

Tularemia

Research

NIAID supports research on the diagnosis, prevention, and treatment of infections caused by microbes, including those that have the potential for use as biological weapons. The research program to address biodefense includes both short- and long-term studies targeted at designing, developing, evaluating, and approving specific tools (diagnostics, therapies, and vaccines) needed to defend against possible bioterrorist-caused disease outbreaks.

NIAID research goals to diagnose, prevent, and treat tularemia include

Supporting basic research to identify mechanisms of Francisella tularensis virulence and pathogenesis, and to define host responses to pathogen

Developing quick and inexpensive ways to diagnose tularemia

Developing antimicrobials and immunotherapies with novel mechanisms of action to treat tularemia

Identifying new F. tularensis vaccine candidates that can prevent or modulate infection both before and after exposure